Characteristics and management of hepatocellular carcinoma (HCC) in Sicily: first results of the HCC Sicily Multidisciplinary Network
C. Celsa,G. Cabibbo,R. Ciccia,G. Di Maria,D. Pagano,R. Miraglia,L. Maruzzelli,M.G. Bavetta,M.R. Barcellona,C. Cocuzza,M. Tavarelli,R. F,C. Pitrone,G. Malizia,G. Bertino,F. Salomone,M. Distefano,M. Mitra,F. Cartabellotta,L. Giannitrapani,D. Giuffrida,M. Spada,G. Alaimo,D. Sambataro,G. Sportato,M.V. Grassini,R. Cannella,M. Antonucci,F. D'Amato,L. Capodicasa,A. Grova,S. Rao,M. Salvato,G. Cusimano,V. Gaudioso,A. Sparacino,F. Mercurio,M. Rizzo,V. Picciotto,R. Montenegro,S. Arena,C. Saitta,M. Russello,G. Fusco,V. Di Marco,S. Gruttadauria,C. Cammà
DOI: https://doi.org/10.1016/j.dld.2024.01.145
IF: 5.165
2024-02-01
Digestive and Liver Disease
Abstract:Introduction Hepatocellular carcinoma (HCC) is constantly increasing in incidence, representing the third cause of cancer death worldwide. Multidisciplinary networks have shown to be effective in improving patient outcomes. Aim To describe the characteristics and management of HCC in Sicily (Italy). Materials & Methods HCC-Sicily-Network is a region-wide observational cohort initiated in November 2021, aiming to include all patients with HCC managed in a real-life situation by a multidisciplinary network. Up to November 2023, 1422 patients were included from 15 centres. In this first phase of the study, we reported clinical, biological, radiological and therapeutic characteristics of 546 patients who received active treatments before study enrolment. Results Median age was 72 years, 77.3% were men, median BMI was 24 kg/m2. HCC was diagnosed by surveillance programs in 52.4% of cases and diagnosed by liver biopsy in 10.1%. Cirrhosis was present in 88.3% of cases, with median MELD 8(IQR 7–10), Child-Pugh A in 56.8%, ALBI grade 1 in 46.5% and grade 3 in 2.5%, grade ≥2 esophageal varices in 22.2%. Etiologies were at least HCV infection in 60.3%, metabolic syndrome in 18.3%, alcohol in 10.3%, HBV in 10.4%. HCC was diagnosed as single nodule in 70.3%, 2 nodules in 15.4%, ≥3 nodules in 14.3%, with median AFP levels 4.5 ng/ml (IQR 2.3–34.5), portal thrombosis in 7.3% and extrahepatic disease in 6.2%. BCLC stages 0, A, B and C were 27.9%, 44.9%, 11.6%, and 15.6%, respectively. Treatment modalities were liver transplant in 4.6%, surgical resection in 28.9%, ablation in 39.2%, intra-arterial treatments in 60.8% and systemic treatment in 15.6%. Conclusion The first analysis of the HCC-Sicily-Network provides real-life data on clinical characteristics and therapeutic management of HCC patients in Sicily before the institution of the network. These will serve as benchmark for the second prospective study phase to assess if the institution of this network model is effective in improving patient outcomes.
gastroenterology & hepatology